Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1179-187X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) ; volume:13 ; number:1 ; day:24 ; month:1 ; year:2013 ; pages:47-56 ; date:2.2013
American journal of cardiovascular drugs ; 13, Heft 1 (24.1.2013), 47-56, 2.2013

Creator: Park, Jeong Bae
Sung, Ki-Chul
Kang, Seok-Min
Cho, Eun Joo

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40256-013-0004-9

URN: urn:nbn:de:101:1-2019113009520474176227

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Park, Jeong Bae
Sung, Ki-Chul
Kang, Seok-Min
Cho, Eun Joo
SpringerLink (Online service)

Other Objects (12)

Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study

Trazodone for the treatment of fibromyalgia: an open-label, 12-week study

Botulinum toxin type A for painful diabetic neuropathy: an open-label study

Duloxetine in the treatment of major depressive disorder: an open-label study

Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone

Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013)

Landiolol is effective and safe in paediatric supraventricular tachycardia: Evidence from a European prospective multicentre open-label Phase III study (LANDI-PED)

Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension

Structured physical exercise for bipolar depression: an open-label, proof-of concept study

Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study

An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin

Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study

Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study

Trazodone for the treatment of fibromyalgia: an open-label, 12-week study

Botulinum toxin type A for painful diabetic neuropathy: an open-label study

Duloxetine in the treatment of major depressive disorder: an open-label study

Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone

Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013)

Landiolol is effective and safe in paediatric supraventricular tachycardia: Evidence from a European prospective multicentre open-label Phase III study (LANDI-PED)

Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension

Structured physical exercise for bipolar depression: an open-label, proof-of concept study

Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study

An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin

Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study

Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study

Trazodone for the treatment of fibromyalgia: an open-label, 12-week study

Botulinum toxin type A for painful diabetic neuropathy: an open-label study

Duloxetine in the treatment of major depressive disorder: an open-label study

Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone

Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013)

Landiolol is effective and safe in paediatric supraventricular tachycardia: Evidence from a European prospective multicentre open-label Phase III study (LANDI-PED)

Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension

Structured physical exercise for bipolar depression: an open-label, proof-of concept study

Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study

An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin

Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study

Trazodone for the treatment of fibromyalgia: an open-label, 12-week study

Botulinum toxin type A for painful diabetic neuropathy: an open-label study

Duloxetine in the treatment of major depressive disorder: an open-label study

Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone

Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013)

Landiolol is effective and safe in paediatric supraventricular tachycardia: Evidence from a European prospective multicentre open-label Phase III study (LANDI-PED)

Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension

Structured physical exercise for bipolar depression: an open-label, proof-of concept study

Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study

An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin

Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study

Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study

Trazodone for the treatment of fibromyalgia: an open-label, 12-week study

Botulinum toxin type A for painful diabetic neuropathy: an open-label study

Duloxetine in the treatment of major depressive disorder: an open-label study

Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone

Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013)

Landiolol is effective and safe in paediatric supraventricular tachycardia: Evidence from a European prospective multicentre open-label Phase III study (LANDI-PED)

Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension

Structured physical exercise for bipolar depression: an open-label, proof-of concept study

Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study

An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin

Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study

Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study

Trazodone for the treatment of fibromyalgia: an open-label, 12-week study

Botulinum toxin type A for painful diabetic neuropathy: an open-label study

Duloxetine in the treatment of major depressive disorder: an open-label study

Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone

Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013)

Landiolol is effective and safe in paediatric supraventricular tachycardia: Evidence from a European prospective multicentre open-label Phase III study (LANDI-PED)

Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension

Structured physical exercise for bipolar depression: an open-label, proof-of concept study

Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study

An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin

Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study

Related objects

Reset password